Research Progress of Role and Mechanism of SETD7 in Tumor Occurrence and Progression
The occurence and development of tumors is a complicated process, which not only depends on the mutation or deletion of genes, but also is affected by epigenetic regulation. Accumulating evidences have shown that epigenetic modifications play fundamental roles in transcriptional regulation, heteroch...
| Published in: | Chinese Journal of Lung Cancer |
|---|---|
| Main Authors: | Limin CAO, Min WANG, Ke XU |
| Format: | Article |
| Language: | Chinese |
| Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2023-01-01
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2023.106.02 |
Similar Items
The Epigenetic Regulation of Nonhistone Proteins by SETD7: New Targets in Cancer
by: Chengyao Chiang, et al.
Published: (2022-06-01)
by: Chengyao Chiang, et al.
Published: (2022-06-01)
Lysine methyltransferase SETD6 modifies histones on a glycine-lysine motif
by: Olivier Binda
Published: (2020-02-01)
by: Olivier Binda
Published: (2020-02-01)
SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model, and its catalytic activity is regulated by histone acetylation
by: Ricardo J Mack, et al.
Published: (2025-09-01)
by: Ricardo J Mack, et al.
Published: (2025-09-01)
SETD2 mutations in primary central nervous system tumors
by: Angela N. Viaene, et al.
Published: (2018-11-01)
by: Angela N. Viaene, et al.
Published: (2018-11-01)
Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton
by: Christina Michail, et al.
Published: (2025-01-01)
by: Christina Michail, et al.
Published: (2025-01-01)
Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients
by: Suwei Wang, et al.
Published: (2019-03-01)
by: Suwei Wang, et al.
Published: (2019-03-01)
SUMOylation of SETD8 Promotes Tumor Growth by Methylating and Stabilizing MYC in Bladder Cancer
by: Xia Zhang, et al.
Published: (2025-05-01)
by: Xia Zhang, et al.
Published: (2025-05-01)
Research progress on histone acetylation/methylation in oral diseases
by: LUO Yuchuan, LI Feifei, YU Fanyuan, YIN Bei, YE Ling
Published: (2024-06-01)
by: LUO Yuchuan, LI Feifei, YU Fanyuan, YIN Bei, YE Ling
Published: (2024-06-01)
Downregulation of trimethyl transferase SETD2 promotes migration and proliferation of colorectal cancer cell
by: CUI Ang, DING Jiazeng, CHEN Haizhen, SHEN Xiaohui, LI Chaofei, LIU Guoliang
Published: (2020-03-01)
by: CUI Ang, DING Jiazeng, CHEN Haizhen, SHEN Xiaohui, LI Chaofei, LIU Guoliang
Published: (2020-03-01)
The Structure, Activity, and Function of the SETD3 Protein Histidine Methyltransferase
by: Apolonia Witecka, et al.
Published: (2021-10-01)
by: Apolonia Witecka, et al.
Published: (2021-10-01)
Elevated levels of the methyltransferase SETD2 causes transcription and alternative splicing changes resulting in oncogenic phenotypes
by: Saikat Bhattacharya, et al.
Published: (2022-08-01)
by: Saikat Bhattacharya, et al.
Published: (2022-08-01)
Mechanisms of Substrate Recognition by the Multispecific Protein Lysine Methyltransferase SETD6
by: Gizem T. Ulu, et al.
Published: (2025-10-01)
by: Gizem T. Ulu, et al.
Published: (2025-10-01)
The functions of SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) in biological process and disease
by: Hanshen Luo, et al.
Published: (2023-12-01)
by: Hanshen Luo, et al.
Published: (2023-12-01)
Current perspectives in Set7 mediated stem cell differentiation
by: Nazanin Karimnia, et al.
Published: (2016-12-01)
by: Nazanin Karimnia, et al.
Published: (2016-12-01)
SET1/MLL family of proteins: functions beyond histone methylation
by: Jeyapal Sugeedha, et al.
Published: (2021-05-01)
by: Jeyapal Sugeedha, et al.
Published: (2021-05-01)
Aberrant histone modifications in pediatric brain tumors
by: Erin T. Hamanishi, et al.
Published: (2025-06-01)
by: Erin T. Hamanishi, et al.
Published: (2025-06-01)
Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathway
by: Chunxiao Ma, et al.
Published: (2023-11-01)
by: Chunxiao Ma, et al.
Published: (2023-11-01)
Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer
by: Miku Wada, et al.
Published: (2020-12-01)
by: Miku Wada, et al.
Published: (2020-12-01)
USP29 Deubiquitinates SETD8 and Regulates DNA Damage-Induced H4K20 Monomethylation and 53BP1 Focus Formation
by: Yeray Hernández-Reyes, et al.
Published: (2022-08-01)
by: Yeray Hernández-Reyes, et al.
Published: (2022-08-01)
Histone modification in Saccharomyces cerevisiae: A review of the current status
by: Kwon Young Chou, et al.
Published: (2023-01-01)
by: Kwon Young Chou, et al.
Published: (2023-01-01)
Proteome-wide Prediction of Lysine Methylation Leads to Identification of H2BK43 Methylation and Outlines the Potential Methyllysine Proteome
by: Kyle K. Biggar, et al.
Published: (2020-07-01)
by: Kyle K. Biggar, et al.
Published: (2020-07-01)
SETD2, an epigenetic tumor suppressor: a focused review on GI tumor
by: Ming Hu, et al.
Published: (2020-01-01)
by: Ming Hu, et al.
Published: (2020-01-01)
Role of Epigenetic Mechanisms in Chronic Pain
by: Daniela Mauceri
Published: (2022-08-01)
by: Daniela Mauceri
Published: (2022-08-01)
Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives
by: Jingjing Pu, et al.
Published: (2024-04-01)
by: Jingjing Pu, et al.
Published: (2024-04-01)
Structure, activity and function of the lysine methyltransferase SETD5
by: Mingyang Li, et al.
Published: (2023-02-01)
by: Mingyang Li, et al.
Published: (2023-02-01)
SETD8 inhibits ferroptosis in pancreatic cancer by inhibiting the expression of RRAD
by: Zekun Lu, et al.
Published: (2023-03-01)
by: Zekun Lu, et al.
Published: (2023-03-01)
Identification of SETD4 as an Onco‐Immunological Biomarker Encompassing the Tumor Microenvironment, Prognoses, and Therapeutic Responses in Various Human Cancers
by: Yuyun Zhong, et al.
Published: (2025-01-01)
by: Yuyun Zhong, et al.
Published: (2025-01-01)
Multiple functions of the lysine methyltransferase KMT5a in cancer: potential targets for innovative therapies
by: Rosa Della Monica, et al.
Published: (2025-09-01)
by: Rosa Della Monica, et al.
Published: (2025-09-01)
SETD2 in MLL-rearranged leukemia – a complex case
by: Anna Skucha, et al.
Published: (2018-07-01)
by: Anna Skucha, et al.
Published: (2018-07-01)
Research progress and applications of epigenetic biomarkers in cancer
by: Jianjun Gao, et al.
Published: (2024-04-01)
by: Jianjun Gao, et al.
Published: (2024-04-01)
Small Molecules Targeting the Specific Domains of Histone-Mark Readers in Cancer Therapy
by: Huihui Zhu, et al.
Published: (2020-01-01)
by: Huihui Zhu, et al.
Published: (2020-01-01)
Histone methylation and acetylation in cancer: mechanism, progression, and targets
by: Bu Su, et al.
Published: (2024-09-01)
by: Bu Su, et al.
Published: (2024-09-01)
Mutual interaction of lncRNAs and epigenetics: focusing on cancer
by: Maryam Ranjbar, et al.
Published: (2023-03-01)
by: Maryam Ranjbar, et al.
Published: (2023-03-01)
Histone modifications and their roles in macrophage-mediated inflammation: a new target for diabetic wound healing
by: Jing Wang, et al.
Published: (2024-08-01)
by: Jing Wang, et al.
Published: (2024-08-01)
SETD5 in glioma cells conferred TRAIL resistance induction
by: Lakshay Taneja, et al.
Published: (2025-09-01)
by: Lakshay Taneja, et al.
Published: (2025-09-01)
Epigenetic regulation of histone modifications in glioblastoma: recent advances and therapeutic insights
by: Li Zhang, et al.
Published: (2025-05-01)
by: Li Zhang, et al.
Published: (2025-05-01)
Role of Histone Modifications in Kidney Fibrosis
by: Shengyu Pan, et al.
Published: (2024-05-01)
by: Shengyu Pan, et al.
Published: (2024-05-01)
SETD7 drives diabetic endothelial dysfunction through FBXO45-mediated GPX4 ubiquitylation
by: Wen Zhong, et al.
Published: (2025-04-01)
by: Wen Zhong, et al.
Published: (2025-04-01)
SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy
by: Xiaobin Zheng, et al.
Published: (2023-07-01)
by: Xiaobin Zheng, et al.
Published: (2023-07-01)
Histone H3 variants at the root of metastasis
by: Didem Ilter, et al.
Published: (2020-03-01)
by: Didem Ilter, et al.
Published: (2020-03-01)
Similar Items
-
The Epigenetic Regulation of Nonhistone Proteins by SETD7: New Targets in Cancer
by: Chengyao Chiang, et al.
Published: (2022-06-01) -
Lysine methyltransferase SETD6 modifies histones on a glycine-lysine motif
by: Olivier Binda
Published: (2020-02-01) -
SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model, and its catalytic activity is regulated by histone acetylation
by: Ricardo J Mack, et al.
Published: (2025-09-01) -
SETD2 mutations in primary central nervous system tumors
by: Angela N. Viaene, et al.
Published: (2018-11-01) -
Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton
by: Christina Michail, et al.
Published: (2025-01-01)
